Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Sitero Extends Ash, a Clinical AI Agent, Across the Full Clinical Data Lifecycle

Sitero's transparent PNG logo

News provided by

Sitero, LLC

Aug 18, 2026, 08:08 ET

Share this article

Share toX

Share this article

Share toX

Sitero today released three Ash agentic workflows simultaneously, covering clinical study setup, continuous data review, and portfolio-level insights, all governed by human review at every step.

CORAL GABLES, Fla., Aug. 18, 2026 /PRNewswire/ -- Sitero, a clinical research organization (CRO) and clinical technology company, today announced the simultaneous availability of three agentic workflows for Ash, Sitero's clinical AI agent: Ash for Study Configuration, Ash for Data Management, and Ash for Insights. The release spans the full clinical data lifecycle, from the earliest stage of study configuration through ongoing data review and portfolio-level risk visibility. Clinical leaders can learn more and request a walkthrough at sitero.com/ash.

Continue Reading

Underlying all three workflows is SiteroAI, Sitero's clinical intelligence engine purpose-built for GxP environments. SiteroAI continuously ingests and harmonizes data from across the clinical ecosystem, including EDC, IRT/RTSM, central and local labs, ePRO, safety databases, and third-party vendor feeds, into a single, governed data layer. Ash operates directly on SiteroAI, ensuring that every workflow, insight, and recommendation is grounded in a complete, current, and permission-aware view of study data. Rather than connecting AI to siloed systems one at a time, SiteroAI provides a consistent data foundation that makes Ash more accurate, more contextual, and easier to govern.

Sitero's Ash compresses months of clinical study setup and data review into weeks.

Post this

The three agentic workflows share a common governance model: human review at every decision gate, outputs grounded in study-specific source data, permission-aware access controls, and a full audit trail on each action. No Ash agentic workflow makes autonomous clinical, safety, or quality decisions.

  • Ash for Study Configuration enables clinical teams to take a protocol from upload to a fully configured, live study in two weeks, compared to the months-long specification cycles typical of traditional approaches. Teams upload a protocol and receive a structured study draft, including the study tree, visits, forms, fields, codelists, and edit checks, all drawn from SiteroAI's protocol and standards libraries. The team reviews the draft, provides comments, and releases. 

    Ash for Study Configuration also manages the full study setup and change lifecycle. Specification documents are housed in integrated eBinders, keeping all configuration artifacts, including annotated CRFs, edit check specs, data management plans, and amendment histories, organized, versioned, and audit-ready in a single location. eSignature workflows allow qualified team members to review and sign off on specifications electronically, eliminating the delays and manual coordination of traditional approval cycles. When a protocol amendment or study change is initiated, Ash identifies the downstream impact across the study build, routes updated specs for review and signature, and updates the eBinder, compressing what has historically been a weeks-long change management process into days. By compressing the configuration-to-go-live timeline from months to weeks and making subsequent study changes faster and less error-prone, Ash for Study Configuration allows sponsors to open enrollment sooner and respond to protocol changes without disrupting study momentum.

  • Ash for Data Management delivered more than 180 data review program checks configured in approximately five weeks in an early deployment with a top-ten pharmaceutical company, compared to an estimated three to four months using traditional SAS-based methods, approximately 75% faster. The workflow provides continuous data review, query management, and vendor reconciliation through two integrated capabilities. The DM Workbench gives data managers a single, role-based workspace where reviews are auto-assigned based on data type, therapeutic area, and team structure, eliminating manual triage and ensuring the right reviewer sees the right data. Ash surfaces only relevant data issues to each team member, filtering out noise so that DM teams are alerted to what matters rather than overwhelmed by volume. Clean Patient Tracker delivers per-subject readiness status, open blockers, and query history in a unified view. Data issues surface as they occur rather than waiting for the next scheduled review. Every check generates a logged entry in the audit trail.

  • Ash for Insights provides study and portfolio-level dashboards with database lock forecasting. Teams can track clean patient status, query trends, and lock readiness continuously throughout the study rather than at the point of lock. Portfolio visibility across multiple concurrent studies is available in a single view, giving clinical operations and leadership an always-current picture of trial health without waiting for end-of-study rollups.

"Clinical teams do not need another disconnected AI tool or generic assistant layered on top of their systems. They need AI that works from a single, trusted view of their study data, fits into a defined clinical workflow, supports accountable review, and leaves a traceable record. SiteroAI gives Ash that foundation, and today's release of three workflows reflects our belief that the value of clinical AI is only realized when configuration, data review, and risk visibility work together." — Sankesh Abbhi, Chief Executive Officer, Sitero

Ash operates on a cloud-native architecture with a natural-language-native interface. The platform is built with GxP compliance support, data governance controls, security, and data lifecycle management. Ash is designed to work alongside a sponsor's existing systems, including EDC, RTSM, and third-party data sources, via APIs and SDKs, with SiteroAI serving as the integration and harmonization layer.

Sitero's AI roadmap extends Ash beyond the current three agentic workflows. Next-horizon capabilities in active development include Ash for SDTM automation, Ash for Medical Monitoring, and Ash for RBQM. 

Clinical leaders can learn more about Ash and its agentic workflows and request a walkthrough at sitero.com/ash.

About Sitero
Sitero is a global clinical research organization combining proprietary technology with clinical services to help sponsors run faster, more efficient trials. Sitero's clinical AI agent, Ash, executes agentic workflows across study configuration, data management, and clinical insights, purpose-built for GxP environments and governed by human review at every step.

MEDIA CONTACT

Anand Rao
Head of Global Marketing, Sitero
[email protected]

SOURCE Sitero, LLC

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Sitero Acquires StudyOS and Launches SiteroAI, Becoming the Industry's First Truly AI-Powered CRO

Sitero Acquires StudyOS and Launches SiteroAI, Becoming the Industry's First Truly AI-Powered CRO

Sitero, a technology-enabled Clinical Research Organization (CRO), today announced it has acquired the AI assets and business of studyOS - a novel...

More Releases From This Source

Explore

Data Analytics

Data Analytics

Data Analytics

Data Analytics

Artificial Intelligence

Artificial Intelligence

The Latest Artificial Intelligence News

The Latest Artificial Intelligence News

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.